Final results of a Phase I study of cediranib, a VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors

被引：1
|
作者：
Murakami, H. [1 ]
Yamamoto, N. [1 ,3 ]
Boku, N. [2 ]
Yamazaki, K. [2 ]
Yamamoto, N. [1 ,3 ]
Yamada, Y. [4 ]
Yamada, K. [3 ]
Puchalski, T. [5 ]
Shin, E. [6 ]
Tamura, T. [3 ]
机构：
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka 104, Japan
[2] Shizuoka Canc Ctr, Div Gastrointestinal Oncol & Endoscopy, Shizuoka 104, Japan
[3] Natl Canc Ctr, Div Internal Med, Tokyo, Japan
[4] Natl Canc Ctr, Div Gastrointestinal Oncol, Tokyo, Japan
[5] AstraZeneca, Res & Dev, Wilmington, DE USA
[6] AstraZeneca, Res & Dev, Osaka, Japan
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72328-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [41] A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors
    Doi, Toshihiko
    Fuse, Nozomu
    Yoshino, Takayuki
    Kojima, Takashi
    Bando, Hideaki
    Miyamoto, Hideaki
    Kaneko, Masato
    Osada, Motonobu
    Ohtsu, Atsushi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 89 - 98
  • [42] Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors
    Yutaka Fujiwara
    Hiroshi Nokihara
    Yasuhide Yamada
    Noboru Yamamoto
    Kuniko Sunami
    Hirofumi Utsumi
    Hiroya Asou
    Osamu TakahashI
    Ken Ogasawara
    Ivelina Gueorguieva
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1143 - 1152
  • [43] Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors
    Toshihiko Doi
    James Chih-Hsin Yang
    Kohei Shitara
    Yoichi Naito
    Ann-Lii Cheng
    Akiko Sarashina
    Linda C. Pronk
    Yoshito Takeuchi
    Chia-Chi Lin
    Targeted Oncology, 2019, 14 : 57 - 65
  • [44] A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors
    Watanabe, K.
    Otsu, S.
    Hirashima, Y.
    Morinaga, R.
    Nishikawa, K.
    Hisamatsu, Y.
    Shimokata, T.
    Inada-Inoue, M.
    Shibata, T.
    Takeuchi, H.
    Watanabe, T.
    Tokushige, K.
    Maacke, H.
    Shiaro, K.
    Ando, Y.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1157 - 1164
  • [45] A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors
    K. Watanabe
    S. Otsu
    Y. Hirashima
    R. Morinaga
    K. Nishikawa
    Y. Hisamatsu
    T. Shimokata
    M. Inada-Inoue
    T. Shibata
    H. Takeuchi
    T. Watanabe
    K. Tokushige
    H. Maacke
    K. Shiaro
    Y. Ando
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1157 - 1164
  • [46] Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors
    Matsumoto, Koji
    Sunaga, Yoshinori
    Ecstein-Fraisse, Evelyne
    Fujiwara, Keiichi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 586 - 593
  • [47] A phase I study of dovitinib (TKI258) in Japanese patients with advanced solid tumors
    Takiuchi, Hiroya
    Gotoh, Masahiro
    Yoshida, Motoki
    Kii, Takayuki
    Yamashita, Keishi
    Sunakawa, Yu
    Kaneta, Toshikado
    Robson, Matthew
    Kakizume, Tomoyuki
    Sasaki, Yasutsuna
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Phase I study of single-agent ribociclib in Japanese patients with advanced solid tumors
    Doi, Toshihiko
    Hewes, Becker
    Kakizume, Tomoyuki
    Tajima, Takeshi
    Ishikawa, Norifumi
    Yamada, Yasuhide
    CANCER SCIENCE, 2018, 109 (01): : 193 - 198
  • [49] A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Kazuhiko Yamada
    Taizo Hirata
    Yasushi Goto
    Maki Tanioka
    Yoko Ikeda
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 559 - 565
  • [50] A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Yamada, Kazuhiko
    Hirata, Taizo
    Goto, Yasushi
    Tanioka, Maki
    Ikeda, Yoko
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 559 - 565
12345